Explore All 68 Merger Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 13, 2025 |
| Target | Endo International |
| Sector | Medical Products |
| Buyer(s) | Mallinckrodt |
| Deal Type | Merger |
| Deal Value | 80M USD |
| Advisor(s) | Goldman Sachs (Financial) Davis Polk & Wardwell Paul, Weiss, Rifkind, Wharton & Garrison A&L Goodbody (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1867 |
| Sector | Life Science |
| Employees | 2,673 |
| Revenue | 2.2B USD (2021) |
Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. Mallinckrodt was founded in 1867 and is based in Dublin, Ireland.
| Deal Context for Buyer | # |
|---|---|
| Overall | 13 of 13 |
| Sector: Medical Products | 4 of 4 |
| Type: Merger | 1 of 1 |
| Country: Ireland | 1 of 1 |
| Year: 2025 | 1 of 1 |
| Size (of disclosed) | 8 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-08-05 |
Therakos
West Chester, Pennsylvania, United States Therakos is a fully integrated extracorporeal photopheresis (ECP) delivery system for autologous immunomodulatory therapy. Therakos is based in West Chester, Pennsylvania. |
Sell | $925M |
